Abstract
Among bioactive peptides derived from aquatic protein, those with ACE inhibitory activity are receiving special attention. This paper presented an overview of ACE inhibitory peptides derived from aquatic proteins, and the peptide sources were listed. The structure-activity relationship and mechanism of action of ACE inhibitory peptides were also discussed. Finally, the antihypertensive effects of ACE inhibitory peptides derived from marine protein, including short-term and long-term influence, were also discussed.
Keywords: Aquatic protein; bioactive peptides; angiotensin converting enzyme; antihypertensive.
Current Protein & Peptide Science
Title:ACE Inhibitory Peptides Derived from Aquatic Protein
Volume: 14 Issue: 3
Author(s): Lin Lin, Shun Lv, Xiaorong Zhang, Jianfeng Lu, Yingwang Ye and Shaotong Jiang
Affiliation:
Keywords: Aquatic protein; bioactive peptides; angiotensin converting enzyme; antihypertensive.
Abstract: Among bioactive peptides derived from aquatic protein, those with ACE inhibitory activity are receiving special attention. This paper presented an overview of ACE inhibitory peptides derived from aquatic proteins, and the peptide sources were listed. The structure-activity relationship and mechanism of action of ACE inhibitory peptides were also discussed. Finally, the antihypertensive effects of ACE inhibitory peptides derived from marine protein, including short-term and long-term influence, were also discussed.
Export Options
About this article
Cite this article as:
Lin Lin, Lv Shun, Zhang Xiaorong, Lu Jianfeng, Ye Yingwang and Jiang Shaotong, ACE Inhibitory Peptides Derived from Aquatic Protein, Current Protein & Peptide Science 2013; 14 (3) . https://dx.doi.org/10.2174/13892037113149990040
DOI https://dx.doi.org/10.2174/13892037113149990040 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiovascular Effects Mediated by Imidazoline Drugs: An Update
Cardiovascular & Hematological Disorders-Drug Targets Hairy Roots, their Multiple Applications and Recent Patents
Recent Patents on Biotechnology Synthesis and Bioactivity of (R)-Ricinoleic Acid Derivatives: A Review
Current Medicinal Chemistry Understanding the Cardiovascular Actions of Soy Isoflavones: Potential Novel Targets for Antihypertensive Drug Development
Cardiovascular & Hematological Disorders-Drug Targets Advances in Biologic Agents for the Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Novel Anti-arrhythmic Medications in the Treatment of Atrial Fibrillation
Current Cardiology Reviews Role of Salt and Potassium in Hypertension and the Associated Organ Damages
Current Hypertension Reviews Catheter Ablation of Lone Atrial Fibrillation
Current Pharmaceutical Design Pharmacological Effects of RAAS Blockade in Ischemic Nephropathy
Current Drug Metabolism An Introduction to the Nutrition and Metabolism of Choline
Central Nervous System Agents in Medicinal Chemistry Preterm Labour: An Overview of Current and Emerging Therapeutics
Current Medicinal Chemistry Traditional Chinese Medicine - Sea Urchin
Mini-Reviews in Medicinal Chemistry Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety
Current Pharmaceutical Design Vasoactive Compounds in the Neonatal Period
Current Medicinal Chemistry Antisense Oligonucleotides in the Treatment of Cerebral Gliomas. Review of Concerning Patents
Recent Patents on CNS Drug Discovery (Discontinued) Cardiovascular Effects of Hypoglycemic Agents in Diabetes Mellitus
Current Drug Safety Aliskiren, a Direct Renin Inhibitor, in Clinical Practice: A New Approach in the Treatment of Hypertension
Current Vascular Pharmacology Pharmacological Approaches to Chronic Spinal Cord Injury
Current Pharmaceutical Design Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials
Current Diabetes Reviews Is Mania the Hypertension of the Mood? Discussion of A Hypothesis
Current Neuropharmacology